This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Aug;110(2):97-8.

doi: 10.1002/jso.23648. Epub 2014 Jun 4.

Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer

James M Donahue¹

Affiliations

PMID: 24895315
DOI: 10.1002/jso.23648

Editorial

Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer

James M Donahue. J Surg Oncol. 2014 Aug.

. 2014 Aug;110(2):97-8.

doi: 10.1002/jso.23648. Epub 2014 Jun 4.

Author

James M Donahue¹

Affiliation

¹ Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.

PMID: 24895315
DOI: 10.1002/jso.23648

No abstract available

PubMed Disclaimer

Similar articles

Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J. Hyogotani A, et al. Clin Lung Cancer. 2012 Sep;13(5):375-84. doi: 10.1016/j.cllc.2011.11.006. Epub 2012 Jan 27. Clin Lung Cancer. 2012. PMID: 22284440
Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA, Tsao MS. Shepherd FA, et al. J Clin Oncol. 2010 Feb 20;28(6):903-5. doi: 10.1200/JCO.2009.26.3996. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100955 No abstract available.
High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
Gately K, Forde L, Cuffe S, Cummins R, Kay EW, Feuerhake F, O'Byrne KJ. Gately K, et al. Clin Lung Cancer. 2014 Jan;15(1):58-66. doi: 10.1016/j.cllc.2013.08.005. Epub 2013 Nov 7. Clin Lung Cancer. 2014. PMID: 24210543
Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.
Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lehmann S, Solèr M, Stulz P, Mihatsch MJ, Gudat F. Dalquen P, et al. J Pathol. 1996 Jan;178(1):53-8. doi: 10.1002/(SICI)1096-9896(199601)178:1<53::AID-PATH415>3.0.CO;2-T. J Pathol. 1996. PMID: 8778317 Review.
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
Zhu CQ, Shih W, Ling CH, Tsao MS. Zhu CQ, et al. J Clin Pathol. 2006 Aug;59(8):790-800. doi: 10.1136/jcp.2005.031351. J Clin Pathol. 2006. PMID: 16873561 Free PMC article. Review.

See all similar articles

Cited by

Multiple primary lung cancer: a rising challenge.
Chen C, Huang X, Peng M, Liu W, Yu F, Wang X. Chen C, et al. J Thorac Dis. 2019 Mar;11(Suppl 4):S523-S536. doi: 10.21037/jtd.2019.01.56. J Thorac Dis. 2019. PMID: 31032071 Free PMC article. Review.
Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y. Lu W, et al. Mol Cancer. 2017 Jul 11;16(1):118. doi: 10.1186/s12943-017-0685-9. Mol Cancer. 2017. PMID: 28697764 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal